Pfizer and BioNTech's vaccine was approved by the U.K.
The decision by the U.K. to approve the vaccine for emergency use came ahead of expected approvals from the U.S. and the European Union.
The shot will be available to the first round of eligible people in Britain starting next week.
Historic day! In the U.K., we received the 1st regulatory authorization of Pfizer and BioNTech’s COVID19 vaccine. I applaud the Medicines and Healthcare Products Regulatory Agency for its swift & thorough review of our vaccine data & grateful for the trust they have placed in our science," Pfizer CEO Alber Bourla wrote on Twitter.
Jim Cramer said the Pfizer news isn't "being greeted as it should by the stock market," as all three major indices traded lower in intraday trading Wednesday.
This means that the vaccine--which has applied for an emergency use authorization with the Food and Drug Administration--could be rolled out to the U.S. population.
Eric Winograd, senior economist at AllianceBernstein, joined TheStreet to talk about how a vaccine rollout could impact the economy.
You can follow Katherine Ross on Twitter at @byKatherineRoss.
Latest Videos From TheStreet and Jim Cramer:
- Coronavirus: The Latest Numbers on the COVID-19 Pandemic
- What Home Office Tells Jim Cramer About What Comes After Dow 30,000
- Drivers of Disruption and Innovation in the PPE Space
- Why Jim Cramer Is Confident on a Vaccine Rollout
- Jim Cramer: How to Balance Stay-At-Home and Return to Normal Plays
- The 'Motherhood Penalty' Can Unfairly Lower Your Social Security Benefit